« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3
, Pages 246-250
, May 2009
2008 Whitmore Lecture: Radical prostatectomy—where we were and where we are going
References
- . The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol. 2007;177:1632–1635
- . Natural history of low-stage prostatic cancer and the impact of early detection. Urol Clin North Am. 1990;17:689
- . Whitmoreisms: Memorable quotes from Willet F. Whitmore Jr., M.D.. Urology. 2004;63:207–297
- . Changes in the use of radical prostatectomy for treating prostate cancer in the USA. Lancet. 1996;348:963–964
- Scandinavian Prostate Cancer Group Study No. 4. Radical prostatectomy vs. watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–1984
- Short-term health outcome differences between robotic and conventional radical prostatectomy. Urology. 2007;70:945–949
- Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with veil of Aphrodite nerve-sparing: An analysis of 154 consecutive patients. BJU Int. 2006;97:467–472
- High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy. J Urol. 2008;180:2557–2564
- Short-term health outcome differences between robotic and conventional radical prostatectomy. Urology. 2007;70:945–949
- The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J Urol. 2007;178(4 Pt 1):1306–1310
- . Effects of pathologic stage on the learning curve for radical prostatectomy: Evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol. 2008;53:960–966
- Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
- . A structured debate: immediate vs. deferred androgen suppression in prostate cancer-evidence for deferred treatment. J Urol. 2001;166:508–515
- Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007;25:1596–1605
PII: S1078-1439(08)00179-8
doi: 10.1016/j.urolonc.2008.07.022
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 3
, Pages 246-250
, May 2009
